Chao Ming Zhao
Direktor/Vorstandsmitglied bei Fujian Mindong Rejuenation Pharmaceutical Co., Ltd.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Zhong Zheng | M | 56 |
Fujian Mindong Rejuenation Pharmaceutical Co., Ltd.
 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Fujian Mindong Rejuenation Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparations and proprietary Chinese medicines. Its products include citicoline sodium tablets and injection, phenobarbital sodium injection, compound glycyrrhizin injection, and compound taizishen granules. The company was founded on September 24, 1997 and is headquartered in Ningde, China. | 27 Jahre |
| Yuan Lin | F | 36 |
Fujian Mindong Rejuenation Pharmaceutical Co., Ltd.
Fujian Mindong Rejuenation Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Fujian Mindong Rejuenation Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparations and proprietary Chinese medicines. Its products include citicoline sodium tablets and injection, phenobarbital sodium injection, compound glycyrrhizin injection, and compound taizishen granules. The company was founded on September 24, 1997 and is headquartered in Ningde, China. | 9 Jahre |
| Yang Chen | M | 42 |
Fujian Mindong Rejuenation Pharmaceutical Co., Ltd.
Fujian Mindong Rejuenation Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Fujian Mindong Rejuenation Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparations and proprietary Chinese medicines. Its products include citicoline sodium tablets and injection, phenobarbital sodium injection, compound glycyrrhizin injection, and compound taizishen granules. The company was founded on September 24, 1997 and is headquartered in Ningde, China. | 7 Jahre |
| Yong Kui Zhang | M | 51 |
Fujian Mindong Rejuenation Pharmaceutical Co., Ltd.
Fujian Mindong Rejuenation Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Fujian Mindong Rejuenation Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparations and proprietary Chinese medicines. Its products include citicoline sodium tablets and injection, phenobarbital sodium injection, compound glycyrrhizin injection, and compound taizishen granules. The company was founded on September 24, 1997 and is headquartered in Ningde, China. | 4 Jahre |
| Chang Yin Mu | F | 67 |
Fujian Mindong Rejuenation Pharmaceutical Co., Ltd.
Fujian Mindong Rejuenation Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Fujian Mindong Rejuenation Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparations and proprietary Chinese medicines. Its products include citicoline sodium tablets and injection, phenobarbital sodium injection, compound glycyrrhizin injection, and compound taizishen granules. The company was founded on September 24, 1997 and is headquartered in Ningde, China. | 4 Jahre |
| Hai Yan Wang | M | 59 |
Fujian Mindong Rejuenation Pharmaceutical Co., Ltd.
Fujian Mindong Rejuenation Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Fujian Mindong Rejuenation Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparations and proprietary Chinese medicines. Its products include citicoline sodium tablets and injection, phenobarbital sodium injection, compound glycyrrhizin injection, and compound taizishen granules. The company was founded on September 24, 1997 and is headquartered in Ningde, China. | 9 Jahre |
| Tong Jin Lin | M | 71 |
Fujian Mindong Rejuenation Pharmaceutical Co., Ltd.
Fujian Mindong Rejuenation Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Fujian Mindong Rejuenation Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparations and proprietary Chinese medicines. Its products include citicoline sodium tablets and injection, phenobarbital sodium injection, compound glycyrrhizin injection, and compound taizishen granules. The company was founded on September 24, 1997 and is headquartered in Ningde, China. | 11 Jahre |
| Nai Shou You | M | 45 |
Fujian Mindong Rejuenation Pharmaceutical Co., Ltd.
Fujian Mindong Rejuenation Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Fujian Mindong Rejuenation Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparations and proprietary Chinese medicines. Its products include citicoline sodium tablets and injection, phenobarbital sodium injection, compound glycyrrhizin injection, and compound taizishen granules. The company was founded on September 24, 1997 and is headquartered in Ningde, China. | 18 Jahre |
| Min Ji Wei | M | 60 |
Fujian Mindong Rejuenation Pharmaceutical Co., Ltd.
Fujian Mindong Rejuenation Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Fujian Mindong Rejuenation Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparations and proprietary Chinese medicines. Its products include citicoline sodium tablets and injection, phenobarbital sodium injection, compound glycyrrhizin injection, and compound taizishen granules. The company was founded on September 24, 1997 and is headquartered in Ningde, China. | 4 Jahre |
| Si Yu Ma | F | 31 |
Fujian Mindong Rejuenation Pharmaceutical Co., Ltd.
Fujian Mindong Rejuenation Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Fujian Mindong Rejuenation Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparations and proprietary Chinese medicines. Its products include citicoline sodium tablets and injection, phenobarbital sodium injection, compound glycyrrhizin injection, and compound taizishen granules. The company was founded on September 24, 1997 and is headquartered in Ningde, China. | 7 Jahre |
| Zheng Hui Zhang | M | 57 |
Fujian Mindong Rejuenation Pharmaceutical Co., Ltd.
Fujian Mindong Rejuenation Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Fujian Mindong Rejuenation Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparations and proprietary Chinese medicines. Its products include citicoline sodium tablets and injection, phenobarbital sodium injection, compound glycyrrhizin injection, and compound taizishen granules. The company was founded on September 24, 1997 and is headquartered in Ningde, China. | 27 Jahre |
| Xiu Zhen Liu | F | 58 |
Fujian Mindong Rejuenation Pharmaceutical Co., Ltd.
Fujian Mindong Rejuenation Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Fujian Mindong Rejuenation Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparations and proprietary Chinese medicines. Its products include citicoline sodium tablets and injection, phenobarbital sodium injection, compound glycyrrhizin injection, and compound taizishen granules. The company was founded on September 24, 1997 and is headquartered in Ningde, China. | 8 Jahre |
| Chong Chen | M | 70 |
Fuzhou University
| 30 Jahre |
| Ping Yan Lam | M | 72 |
The Chinese University of Hong Kong
| 20 Jahre |
| Jing Wen Chen | F | 36 |
Fujian Mindong Rejuenation Pharmaceutical Co., Ltd.
Fujian Mindong Rejuenation Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Fujian Mindong Rejuenation Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparations and proprietary Chinese medicines. Its products include citicoline sodium tablets and injection, phenobarbital sodium injection, compound glycyrrhizin injection, and compound taizishen granules. The company was founded on September 24, 1997 and is headquartered in Ningde, China. | 4 Jahre |
| Hui Ping Lin | F | 50 |
Fujian Mindong Rejuenation Pharmaceutical Co., Ltd.
Fujian Mindong Rejuenation Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Fujian Mindong Rejuenation Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparations and proprietary Chinese medicines. Its products include citicoline sodium tablets and injection, phenobarbital sodium injection, compound glycyrrhizin injection, and compound taizishen granules. The company was founded on September 24, 1997 and is headquartered in Ningde, China. | 5 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Xiao Ying Gao | M | 74 |
China Biologic Products, Inc.
 China Biologic Products, Inc. Pharmaceuticals: MajorHealth Technology China Biologic Products, Inc. operates as a biopharmaceutical company, which engages in the manufacture and distribution of plasma-based pharmaceutical products and other biological substances. Its products include human albumin, human immunoglobulin for intravenous injection, human Hepatitis B immunoglobulin, human rabies immunoglobulin, human immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, and placenta polypeptide. The company was founded on December 20, 1989 and is headquartered in Beijing, China. | 7 Jahre |
| Lok Yee Li | M | 45 |
The Chinese University of Hong Kong
| 10 Jahre |
| Zhi Jun Tong | M | 64 |
China Biologic Products, Inc.
China Biologic Products, Inc. Pharmaceuticals: MajorHealth Technology China Biologic Products, Inc. operates as a biopharmaceutical company, which engages in the manufacture and distribution of plasma-based pharmaceutical products and other biological substances. Its products include human albumin, human immunoglobulin for intravenous injection, human Hepatitis B immunoglobulin, human rabies immunoglobulin, human immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, and placenta polypeptide. The company was founded on December 20, 1989 and is headquartered in Beijing, China. | - |
| Sandy Zhang | F | 51 |
China Biologic Products, Inc.
China Biologic Products, Inc. Pharmaceuticals: MajorHealth Technology China Biologic Products, Inc. operates as a biopharmaceutical company, which engages in the manufacture and distribution of plasma-based pharmaceutical products and other biological substances. Its products include human albumin, human immunoglobulin for intravenous injection, human Hepatitis B immunoglobulin, human rabies immunoglobulin, human immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, and placenta polypeptide. The company was founded on December 20, 1989 and is headquartered in Beijing, China. | - |
| Wen Fang Liu | M | 87 |
China Biologic Products, Inc.
China Biologic Products, Inc. Pharmaceuticals: MajorHealth Technology China Biologic Products, Inc. operates as a biopharmaceutical company, which engages in the manufacture and distribution of plasma-based pharmaceutical products and other biological substances. Its products include human albumin, human immunoglobulin for intravenous injection, human Hepatitis B immunoglobulin, human rabies immunoglobulin, human immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, and placenta polypeptide. The company was founded on December 20, 1989 and is headquartered in Beijing, China. | - |
| Yun Gang Lu | M | 60 |
China Biologic Products, Inc.
China Biologic Products, Inc. Pharmaceuticals: MajorHealth Technology China Biologic Products, Inc. operates as a biopharmaceutical company, which engages in the manufacture and distribution of plasma-based pharmaceutical products and other biological substances. Its products include human albumin, human immunoglobulin for intravenous injection, human Hepatitis B immunoglobulin, human rabies immunoglobulin, human immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, and placenta polypeptide. The company was founded on December 20, 1989 and is headquartered in Beijing, China. | - |
| Siu Ling Chan | F | 61 |
China Biologic Products, Inc.
China Biologic Products, Inc. Pharmaceuticals: MajorHealth Technology China Biologic Products, Inc. operates as a biopharmaceutical company, which engages in the manufacture and distribution of plasma-based pharmaceutical products and other biological substances. Its products include human albumin, human immunoglobulin for intravenous injection, human Hepatitis B immunoglobulin, human rabies immunoglobulin, human immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, and placenta polypeptide. The company was founded on December 20, 1989 and is headquartered in Beijing, China. | - |
| Xiao Lan Deng | F | 47 |
Fuzhou University
| 7 Jahre |
| Sean Shao | M | 67 |
China Biologic Products, Inc.
China Biologic Products, Inc. Pharmaceuticals: MajorHealth Technology China Biologic Products, Inc. operates as a biopharmaceutical company, which engages in the manufacture and distribution of plasma-based pharmaceutical products and other biological substances. Its products include human albumin, human immunoglobulin for intravenous injection, human Hepatitis B immunoglobulin, human rabies immunoglobulin, human immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, and placenta polypeptide. The company was founded on December 20, 1989 and is headquartered in Beijing, China. | 9 Jahre |
| Albert Yeung | M | 81 |
China Biologic Products, Inc.
China Biologic Products, Inc. Pharmaceuticals: MajorHealth Technology China Biologic Products, Inc. operates as a biopharmaceutical company, which engages in the manufacture and distribution of plasma-based pharmaceutical products and other biological substances. Its products include human albumin, human immunoglobulin for intravenous injection, human Hepatitis B immunoglobulin, human rabies immunoglobulin, human immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, and placenta polypeptide. The company was founded on December 20, 1989 and is headquartered in Beijing, China. | - |
| Ka Ying Leung | F | 37 |
The Chinese University of Hong Kong
| 4 Jahre |
| Ling Chau | M | 41 |
The Chinese University of Hong Kong
| 4 Jahre |
| Po Yi Fok | F | - |
The Chinese University of Hong Kong
| 4 Jahre |
| Tak Ching Poon | M | 41 |
The Chinese University of Hong Kong
| 4 Jahre |
| Man Kin Wong | M | 39 |
The Chinese University of Hong Kong
| 4 Jahre |
| Jun Xiong | M | 50 |
The Chinese University of Hong Kong
| 2 Jahre |
| Pui Kwan Lau | F | 43 |
The Chinese University of Hong Kong
| 4 Jahre |
| Kwok Cheung Li | M | 79 |
The Chinese University of Hong Kong
| 23 Jahre |
| Shing Fung Cheng | M | 40 |
The Chinese University of Hong Kong
| 1 Jahre |
| Kit Ying Chung | F | 49 |
The Chinese University of Hong Kong
| 1 Jahre |
| Yun Li Zou | F | 51 |
The Chinese University of Hong Kong
| 1 Jahre |
| Yuan Jin | M | 49 |
The Chinese University of Hong Kong
| 1 Jahre |
| Wai Hang Fung | M | 38 |
The Chinese University of Hong Kong
| 4 Jahre |
| Siu Chung Au | M | 41 |
The Chinese University of Hong Kong
| 4 Jahre |
| Yuan Ren | F | 50 |
The Chinese University of Hong Kong
| 1 Jahre |
| Ho Kei Chan | M | 37 |
The Chinese University of Hong Kong
| 4 Jahre |
| Zhen Xing Shao | M | 46 |
The Chinese University of Hong Kong
| 2 Jahre |
| Xiao Zhang | F | 36 |
The Chinese University of Hong Kong
| 4 Jahre |
| Tai Shing Chiu | M | 71 |
The Chinese University of Hong Kong
| 1 Jahre |
| Ho Yin Man | M | 41 |
The Chinese University of Hong Kong
| 4 Jahre |
| Yan Jiang | F | 51 |
The Chinese University of Hong Kong
| 2 Jahre |
| Ting Hong | F | 37 |
The Chinese University of Hong Kong
| 4 Jahre |
| Kang Chao Yan | M | 44 |
The Chinese University of Hong Kong
| 1 Jahre |
| Yin Ling Ng | F | 64 |
The Chinese University of Hong Kong
| 2 Jahre |
| Li Jun Ma | M | 45 |
The Chinese University of Hong Kong
| 3 Jahre |
| Wai Sze Lai | F | 52 |
The Chinese University of Hong Kong
| 2 Jahre |
| Xiao Qiong Dou | F | 50 |
The Chinese University of Hong Kong
| 2 Jahre |
| Wing Sze Yu | F | 41 |
The Chinese University of Hong Kong
| 4 Jahre |
| Yin On Choi | M | 40 |
The Chinese University of Hong Kong
| 4 Jahre |
| Sze Lo | M | 40 |
The Chinese University of Hong Kong
| 4 Jahre |
| Hing Bun Kevin Lau | M | 55 |
The Chinese University of Hong Kong
| 2 Jahre |
| Liang Song | M | 42 |
The Chinese University of Hong Kong
| 1 Jahre |
| Shek Ling Leung | M | 52 |
The Chinese University of Hong Kong
| 3 Jahre |
| Jia Hong Zhang | M | 51 |
The Chinese University of Hong Kong
| 2 Jahre |
| Wang Yu Ng | M | 52 |
The Chinese University of Hong Kong
| 2 Jahre |
| Zhi Peng Zhao | M | 40 |
The Chinese University of Hong Kong
| 3 Jahre |
| Hong Li Han | M | 53 |
The Chinese University of Hong Kong
| 1 Jahre |
| Wa Ping Chan | M | 39 |
The Chinese University of Hong Kong
| 4 Jahre |
| Xiao Bo Wang | M | 54 |
The Chinese University of Hong Kong
| 1 Jahre |
| Tie Jun Yang | M | 53 |
The Chinese University of Hong Kong
| 1 Jahre |
| Fung Lin Yeung | F | 48 |
The Chinese University of Hong Kong
| 1 Jahre |
| Yi Ran Xu | M | 52 |
The Chinese University of Hong Kong
| 2 Jahre |
| Hang Yin Tam | F | - |
The Chinese University of Hong Kong
| 2 Jahre |
| Yu Ting Mok | M | 47 |
The Chinese University of Hong Kong
| 3 Jahre |
| Lester Garson Huang | M | 64 |
The Chinese University of Hong Kong
| 1 Jahre |
| Ming Cheung | M | - |
The Chinese University of Hong Kong
| 3 Jahre |
| Ngai Chiu Chai | M | 57 |
The Chinese University of Hong Kong
| 2 Jahre |
| Yue Tan | M | 65 |
The Chinese University of Hong Kong
| 3 Jahre |
| Jerneja Loncar | F | - |
The Chinese University of Hong Kong
| 2 Jahre |
| Guo Zheng Zhang | M | 59 |
The Chinese University of Hong Kong
| 2 Jahre |
| Shao Hua Xie | M | 52 |
The Chinese University of Hong Kong
| 2 Jahre |
| Xu Wang | M | 57 |
The Chinese University of Hong Kong
| 2 Jahre |
| Lai Man Ng | M | 60 |
The Chinese University of Hong Kong
| 2 Jahre |
| Yu Keung Poon | M | 60 |
The Chinese University of Hong Kong
| 2 Jahre |
| Mei Ka Lui | F | 39 |
The Chinese University of Hong Kong
| 4 Jahre |
| Xiang Ming Cui | M | 55 |
China Biologic Products, Inc.
China Biologic Products, Inc. Pharmaceuticals: MajorHealth Technology China Biologic Products, Inc. operates as a biopharmaceutical company, which engages in the manufacture and distribution of plasma-based pharmaceutical products and other biological substances. Its products include human albumin, human immunoglobulin for intravenous injection, human Hepatitis B immunoglobulin, human rabies immunoglobulin, human immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, and placenta polypeptide. The company was founded on December 20, 1989 and is headquartered in Beijing, China. | 1 Jahre |
| Ka Lun Suek | M | 45 |
The Chinese University of Hong Kong
| 2 Jahre |
| Kam Ting Wong | M | 39 |
The Chinese University of Hong Kong
| 4 Jahre |
| Hou Min Yan | M | 69 |
The Chinese University of Hong Kong
| 5 Jahre |
| Wai Ming Wong | M | - |
The Chinese University of Hong Kong
| 3 Jahre |
| Ka Chun Ho | M | 63 |
The Chinese University of Hong Kong
| 4 Jahre |
| Hai Ming Leung | M | 69 |
The Chinese University of Hong Kong
| 3 Jahre |
| Zhan Pang | M | 46 |
The Chinese University of Hong Kong
| 3 Jahre |
| Kin Ting Luk | M | 39 |
The Chinese University of Hong Kong
| 3 Jahre |
| Yong Bo Du | M | 53 |
The Chinese University of Hong Kong
| 2 Jahre |
| Shek Lun Yip | M | 42 |
The Chinese University of Hong Kong
| 4 Jahre |
| Wing Pong Tsang | M | 37 |
The Chinese University of Hong Kong
| 4 Jahre |
| Ching Fung Fok | M | 53 |
The Chinese University of Hong Kong
| 1 Jahre |
| Liang Sheng Shi | M | 42 |
The Chinese University of Hong Kong
| 3 Jahre |
| Rui Si Zhang | F | - |
The Chinese University of Hong Kong
| 4 Jahre |
| Jian Yi Liu | F | 38 |
The Chinese University of Hong Kong
| 4 Jahre |
| Chan In Sio | M | 38 |
The Chinese University of Hong Kong
| 3 Jahre |
| Wai Ting Wan | F | 41 |
The Chinese University of Hong Kong
| 4 Jahre |
| Xiao Ling Lai | M | 48 |
The Chinese University of Hong Kong
| 2 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Hong Kong | 75 | 75,00% |
| China | 25 | 25,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Chao Ming Zhao
- Persönliches Netzwerk